Abalone Bio

Abalone Bio, Inc. is a biotechnology company based in Richmond, California, established in 2017. The company specializes in developing full-spectrum antibody drugs aimed at treating various conditions, including pain, inflammatory diseases, rare cancers, and rare kidney diseases. One of its primary focuses is on creating a drug for peripheral neuropathy. Abalone Bio employs innovative techniques that utilize libraries of yeast cells expressing antibody variants to either activate or inhibit specific drug targets, facilitating the production of recombinant protein versions of its antibodies. This approach allows for the confirmation of their efficacy through human cell assays, ultimately enabling medical practitioners to address rare diseases more effectively.